Cited by 44Sleep and Wakefulness ResearchSleep and related disordersTreatment of Major Depression

Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?

Abstract

In previous uncontrolled studies, nefazodone, a new antidepressant drug, increased REM sleep or had no effect on REM sleep. We report a double-blind, placebo-controlled, parallel group study on effects of nefazodone (N) on polysomnographic sleep variables in healthy human volunteers. Nefazodone was administered for 16 consecutive days, and nocturnal sleep, as well as multiple sleep latency test (MSLT), was monitored before, during, and after N administration. We found that N had no effect on any measured REM sleep variable including REM sleep duration, REM density, and nocturnal REM sleep distribution. Nefazodone also had no significant effect on nocturnal total sleep time or NREM variables, but increased daytime alertness measured by the MSLT. Since N is a potent serotonin reuptake blocker, the present findings that N had no effect on REM sleep cast doubt on the hypothesis that antidepressant drugs decrease REM sleep by increasing serotonergic neurotransmission. A review of other relevant work also casts doubt on this hypothesis.

Integrity signals

Registry

Crossref · 10.1093/sleep/21.1.70

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nefazodone (200-400mg) reduced total sleep time, and increased nocturnal awakenings, when compared to placebo, in 120 healthy volunteers.

    “In contrast to some findings in depressed groups, (Vogel et al., 1998) showed that nefazodone (200400mg) reduced total sleep time, and increased nocturnal awakenings, when compared to placebo, in 120 healthy volunteers.”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Vogel et al., 1998

  • In healthy volunteers, nefazodone 200-400mg left REM time, REM latency, REM density, and REM% unchanged relative to baseline and placebo.

    “REM time, REML, REMD & REM% all remained unchanged, relative to baseline and PLC”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Vogel, 1998

  • In healthy volunteers, total sleep time was significantly less with nefazodone 200-400mg than placebo on day 1 (p<.05), normalised by day 2.

    “TST sig less NEF than PLC day 1 (P<.05), normalised by day 2”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Vogel, 1998

  • In healthy volunteers, wake after sleep onset was significantly more with nefazodone 200-400mg than placebo on day 1 (p<.05).

    “WMINS sig more with NEF than PLC day 1 (p<.05)”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Vogel, 1998

Cited by

Sorted by citations

Authors
Vogel, G., Cohen, J., Mullis, D., Kensler, T., & Kaplita, S.
Corresponding author
Vogel, Gerald
Venue
Sleep
Published
1998-01
Volume
21
Issue
1
Pages
70-77
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W2408487941
Cited by
44
References
0
Citations by year
2025: 1 · 2016: 2 · 2014: 1
FWCI
2.52
Type
journal article
Language
en
Open access
closed
Locations
  • SLEEP (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
nefazodone, REM sleep, antidepressants, REM sleep suppression, serotonin reuptake inhibition, serotonergic neurotransmission, multiple sleep latency test, daytime alertness, polysomnography, REM density, REM sleep duration
MeSH terms
Adolescent, Adult, Female, Humans, Male, Piperazines, Serotonin, Sleep Stages, Sleep, REM, Triazoles, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review